Stage IVA Pancreatic Cancer

11 clinical trials · Condition

Record	Firm	Date
Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer (NCT03095781)	Emory University	2017-07-07
APN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by Surgery (NCT03087591)	Wake Forest University Health Sciences	2017-04-28
Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors (NCT02897375)	Emory University	2016-10-24
TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid Tumors (NCT02650635)	Mayo Clinic	2016-02-05
Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer (NCT02451553)	University of Washington	2015-11-05
Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing Surgery (NCT02511821)	City of Hope Medical Center	2015-07-22
ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer (NCT01825603)	University of Nebraska	2013-04-09
Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer (NCT00323583)	Seattle Cancer Treatment and Wellness Center	2006-05-01
Combination Chemotherapy and Radiation Therapy Plus Surgery in Treating Patients With Advanced Cancer of the Pancreas (NCT00020345)	National Institutes of Health Clinical Center (CC)	2000-09-01
Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer (NCT00019006)	National Cancer Institute (NCI)	1995-03-01

Track Stage IVA Pancreatic Cancer automatically

Every clearance here is in the API, with alerts when new ones post.